Crossmark

Burden of early, advanced and metastatic breast cancer in The Netherlands

Crossref DOI link: https://doi.org/10.1186/s12885-018-4158-3

Published Online: 2018-03-07

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vondeling, G. T. http://orcid.org/0000-0001-6846-2752
Menezes, G. L.

Dvortsin, E. P.

Jansman, F. G. A.

Konings, I. R.

Postma, M. J.

Rozenbaum, M. H.
More Information

Article History

Received: 27 July 2017

Accepted: 21 February 2018

First Online: 7 March 2018

Ethics approval and consent to participate

: No ethical approval was required as an existing database was used and aggregated data was provided by IKNL.

: Not applicable.

: Mark Rozenbaum is employed by Pfizer. All other authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.